Skip to content
Operation Infinite Justice – Lifestyle
Author:
IRulya Therapeutics Inc.
IRulya Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
November 13, 2026
IRulya Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 9, 2026
IRulya Therapeutics to Participate in the Craig-Hallum Biotech Catalyst Conference
October 15, 2026